Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hegde

Showing results (501-510 of 657) with videos related to

Pageof 66
Sort By:
Molecular Cancer Therapeutics|March 2, 2021
Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and AngiogenesisYuhua Wang, Ram Naresh Pandey, Kaushik Roychoudhury, et al.
Science (New York, N.Y.)|June 4, 2005
A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNASubray S Hegde, Matthew W Vetting, Steven L Roderick, et al.
Circulation|October 18, 2000
Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureH N Sabbah, W C Stanley, V G Sharov, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|December 8, 2010
Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patientsMallavarapu R Srividya, Balaram Thota, Bangalore C Shailaja, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal modelsM T Pulido-Rios, A McNamara, G P Obedencio, et al.
Biochemistry|January 4, 2006
Pentapeptide repeat proteinsMatthew W Vetting, Subray S Hegde, J Eduardo Fajardo, et al.
Neurosurgical Focus|May 2, 2018
Comparison of telemedicine with in-person care for follow-up after elective neurosurgery: results of a cost-effectiveness analysis of 1200 patients using patient-perceived utility scoresSumit Thakar, Niranjana Rajagopal, Subramaniyan Mani, et al.
British Journal of Pharmacology|February 1, 1995
Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivoR M Eglen, C H Lee, W L Smith, et al.
The American Journal of Pathology|January 15, 2016
The Eyes Absent Proteins in Developmental and Pathological AngiogenesisYuhua Wang, Emmanuel Tadjuidje, Ram Naresh Pandey, et al.
Nature Structural & Molecular Biology|October 20, 2025
Global analysis of translocon remodeling during protein synthesis at the ERArunkumar Sundaram, Qianru Li, Yu Wan, et al.
Pageof 66

Showing results (501-510 of 657) with videos related to

Sort By:
Pageof 66
Molecular Cancer Therapeutics|March 2, 2021
Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and AngiogenesisYuhua Wang, Ram Naresh Pandey, Kaushik Roychoudhury, et al.
Science (New York, N.Y.)|June 4, 2005
A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNASubray S Hegde, Matthew W Vetting, Steven L Roderick, et al.
Circulation|October 18, 2000
Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureH N Sabbah, W C Stanley, V G Sharov, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|December 8, 2010
Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patientsMallavarapu R Srividya, Balaram Thota, Bangalore C Shailaja, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal modelsM T Pulido-Rios, A McNamara, G P Obedencio, et al.
Biochemistry|January 4, 2006
Pentapeptide repeat proteinsMatthew W Vetting, Subray S Hegde, J Eduardo Fajardo, et al.
Neurosurgical Focus|May 2, 2018
Comparison of telemedicine with in-person care for follow-up after elective neurosurgery: results of a cost-effectiveness analysis of 1200 patients using patient-perceived utility scoresSumit Thakar, Niranjana Rajagopal, Subramaniyan Mani, et al.
British Journal of Pharmacology|February 1, 1995
Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivoR M Eglen, C H Lee, W L Smith, et al.
The American Journal of Pathology|January 15, 2016
The Eyes Absent Proteins in Developmental and Pathological AngiogenesisYuhua Wang, Emmanuel Tadjuidje, Ram Naresh Pandey, et al.
Nature Structural & Molecular Biology|October 20, 2025
Global analysis of translocon remodeling during protein synthesis at the ERArunkumar Sundaram, Qianru Li, Yu Wan, et al.
Pageof 66